| 1 |
34641332 | Role of 5-HT1A Receptor in Vilazodone-Mediated Suppression of L-DOPA-Induced Dyskinesia and Increased Responsiveness to Cortical Input in Striatal Medium Spiny Neurons in an Animal Model of Parkinson's Disease. | 2021 Sep 24 |
1 |
| 2 |
32615138 | Improvement of lower urinary tract function by a selective serotonin 5-HT1A receptor agonist, NLX-112, after chronic spinal cord injury. | 2020 Oct |
1 |
| 3 |
29339052 | Neurophysiological effects in cortico-basal ganglia-thalamic circuits of antidyskinetic treatment with 5-HT1A receptor biased agonists. | 2018 Apr |
1 |
| 4 |
25503261 | 5-HT1A receptor-dependent control of nigrostriatal dopamine neurotransmission in the pharmacotherapy of Parkinson's disease and schizophrenia. | 2015 Feb |
1 |
| 5 |
25645393 | Activity of serotonin 5-HT(1A) receptor 'biased agonists' in rat models of Parkinson's disease and L-DOPA-induced dyskinesia. | 2015 Jun |
1 |
| 6 |
25669730 | Eltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson's disease: a dose-finding study. | 2015 Apr |
2 |
| 7 |
26071982 | The highly-selective 5-HT(1A) agonist F15599 reduces L-DOPA-induced dyskinesia without compromising anti-parkinsonian benefits in the MPTP-lesioned macaque. | 2015 Oct |
1 |
| 8 |
26455457 | New insight into the therapeutic role of the serotonergic system in Parkinson's disease. | 2015 Nov |
1 |
| 9 |
23423244 | Improving the Treatment of Parkinson's Disease: A Novel Approach by Modulating 5-HT(1A) Receptors. | 2013 Feb |
1 |
| 10 |
23811734 | The serotonergic system in motor and non-motor manifestations of Parkinson's disease. | 2013 Oct |
1 |
| 11 |
24312874 | Dampening of Serotonergic System through 5HT1A Receptors is a Promising Target for Treatment of Levodopa Induced Motor Problems. | 2013 |
3 |
| 12 |
21051107 | Regulation of cortical and striatal 5-HT1A receptors in the MPTP-lesioned macaque. | 2012 Jan |
4 |
| 13 |
22419526 | Increased levels of 5-HT1A receptor binding in ventral visual pathways in Parkinson's disease. | 2012 May |
1 |
| 14 |
22940695 | Effect of chronic l-DOPA treatment on 5-HT(1A) receptors in parkinsonian monkey brain. | 2012 Dec |
5 |
| 15 |
21091640 | Therapeutic role of 5-HT1A receptors in the treatment of schizophrenia and Parkinson's disease. | 2011 Feb |
1 |
| 16 |
20518729 | New insight into the therapeutic role of 5-HT1A receptors in central nervous system disorders. | 2010 Jun 1 |
1 |
| 17 |
18952677 | Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia. | 2008 Dec |
1 |
| 18 |
17553470 | The differential effects of 5-HT(1A) receptor stimulation on dopamine receptor-mediated abnormal involuntary movements and rotations in the primed hemiparkinsonian rat. | 2007 Jul 16 |
1 |
| 19 |
15791634 | Effects of serotonin 5-HT1A agonist in advanced Parkinson's disease. | 2005 Aug |
2 |
| 20 |
15893579 | A serotonin 5-HT1A receptor agonist prevents behavioral sensitization to L-DOPA in a rodent model of Parkinson's disease. | 2005 Jun |
2 |
| 21 |
12897636 | Mirtazapine in L-dopa-induced dyskinesias. | 2003 Jul-Aug |
1 |
| 22 |
11889759 | [Tandospirone citrate, a selective 5-HT1A agonist, alleviates L-DOPA-induced dyskinesia in patients with Parkinson's disease]. | 2002 Feb |
2 |